Abstract:Identification of molecular mechanisms that regulate glucose-stimulated insulin secretion (GSIS) and β-cell identity and growth are essential to develop therapeutic approaches to treat diabetes. Zinc finger protein 385D (ZNF385D) is a nuclear protein that belongs to the Krüppel C2H2-type zinc-finger protein family. Gene-Wide Association Studies have strongly associated ZNF385D gene variants with type 2 diabetes (T2D) onset. Using scRNA-seq and snRNA-seq of adult nondiabetic human islets, we have recently reported that the ZNF385D gene is specifically expressed in human β cells, and its expression negatively correlates with INS expression. However, the role of ZNF385D in the human β cell is unknown. Here, we have addressed this point by overexpressing ZNF385D in EndoC-βH1 cells and human islets and analyzed gene expression, GSIS, and β cell survival. Mining of scRNA-seq data from human islets of nondiabetic and T2D donors from HIRN-HPAP showed that ZNF385 expression is significantly enhanced while INS expression is significantly decreased in β-cells of T2D islets. Overexpression of ZNF385D in EndoC-βH1 cells and human islets led to significant downregulation of INS, PDX1, MAFA, SLC2A2, SNAP25 and VAMP2 genes and significant upregulation of T2D β-like genes such as RFX7, PPAR γ, PPAR α, RB1, POU5F1, NANOG and MYCL. ZNF385D overexpression significantly reduced GSIS without altering basal secretion. scRNA-seq analysis of human islets showed a positive correlation between ZNF385D expression and activation of senescence, apoptosis and metabolic inflexibility pathways in β-cells. Indeed, β-cell death was significantly enhanced by ZNF385D overexpression after treatment with cytokines (TNFα, IL1β, and IFNγ) as assessed by flow cytometry and TUNEL staining. Taken together, these studies indicate that enhanced expression of the β-cell specific gene ZNF385D causes detrimental effects in the function, identity and survival of the human β-cell leading to a T2D-like phenotype. Disclosure G. Lu: None. R. Kang: None. M.A. Varela: None. E. Oh: None. D.C. Thurmond: Consultant; Truebindings. A. Garcia-Ocana: Consultant; Sun Pharmaceutical Industries Ltd. Funding AR-DMRI Innovative Award

Novel Loss-of-Function Variant in HNF1a Induces β-Cell Dysfunction through Endoplasmic Reticulum Stress

Novel Loss-of-Function Variant in HNF1a Induces beta-Cell Dysfunction through Endoplasmic Reticulum Stress

Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency

Mutation P291fsinsC in the Transcription Factor Hepatocyte Nuclear Factor-1Alpha is Dominant Negative

Deficiency of Voltage-gated Proton Channel Hv1 Leads to hypoinsulinaemia, hyperglycemia and glucose intolerance in mice

HNF4A and HNF1A exhibit tissue specific target gene regulation in pancreatic beta cells and hepatocytes

Loss of MANF Causes Childhood-Onset Syndromic Diabetes Due to Increased Endoplasmic Reticulum Stress

Investigating the pathogenicity of the recessive HNF1A p.A251T variant in monogenic diabetes using iPSC-derived beta-like cells

Beta-Cell-Targeted Expression of A Dominant-Negative Hepatocyte Nuclear Factor-1 Alpha Induces A Maturity-Onset Diabetes of the Young (Mody)3-Like Phenotype in Transgenic Mice

Loss of Hnrnp A1 in Murine Skeletal Muscle Exacerbates High-Fat Diet-Induced Onset of Insulin Resistance and Hepatic Steatosis.

Transcriptional Regulation of X-Box-binding Protein One (XBP1) by Hepatocyte Nuclear Factor 4α (HNF4Α) Is Vital to Beta-cell Function

Lysine 117 residue is essential for the function of the hepatocyte nuclear factor 1α

Nuclear Factor Κb–inducing Kinase Activation As a Mechanism of Pancreatic Β Cell Failure in Obesity

339-OR: Enhanced Expression of Zinc Finger Protein 385D Leads to Type 2 Diabetes Phenotype in Human Beta Cells

A Novel Hepatocyte Nuclear Factor-1Α Genetic Mutation in a Chinese Pedigree with Maturity-Onset Diabetes of the Young Type 3

Dominant-negative Suppression of HNF-1α Results in Mitochondrial Dysfunction, INS-1 Cell Apoptosis, and Increased Sensitivity to Ceramide-, but Not to High Glucose-induced Cell Death

Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins

Obesity-Induced Regulator of Calcineurin 1 Overexpression Leads to Β-Cell Failure Through Mitophagy Pathway Inhibition

Haploid Insufficiency of Suppressor Enhancer Lin12 1-Like (SEL1L) Protein Predisposes Mice to High Fat Diet-Induced Hyperglycemia.

NPC1 is required for postnatal islet β cell differentiation by maintaining mitochondria turnover

Expression of mutant mRNA and protein in pancreatic cells derived from MODY3- iPS cells